Tygacil - Broad-Spectrum Antibiotic for Empiric Treatment of Serious Infections

Print

There has been a ten-fold increase in rates of vancomycin resistance among gram-positive enterococci between 1990 and 1998.
 
«Back | Next»




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development